| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 10.277 | 1.904 | 3.244 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 41.181 | 2.915 | 3.244 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 34.131 | 9.266 | 879 | 7.758 | 649 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 7.050 | -6.351 | 2.365 | -7.758 | -649 |
| Net Profit/Loss - EUR | - | - | - | - | - | 6.954 | -6.401 | 2.334 | -7.758 | -649 |
| Employees | - | - | - | - | - | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Andralex Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 725 | 284 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 19.349 | 5.960 | 6.165 | 10.228 | 9.179 |
| Inventories | - | - | - | - | - | 5.678 | 5.112 | 5.128 | 5.112 | 5.084 |
| Receivables | - | - | - | - | - | 1.042 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | - | 12.629 | 848 | 1.037 | 5.116 | 4.095 |
| Shareholders Funds | - | - | - | - | - | 6.995 | 439 | 2.775 | -4.992 | -5.613 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 13.755 | 6.464 | 4.053 | 15.880 | 15.448 |
| Income in Advance | - | - | - | - | - | -675 | -660 | -662 | -660 | -656 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Andralex Therapy S.r.l.